P aragangliomas (PGs) are rare extraadrenal neuroendocrine tumors that may appear in all ages, with the highest incidence in the fifth decade of life. PGs are often classified based on their site of origin, with 85% found in the abdomen, 12% in the chest, and 3% in the head and neck region. Carotid PGs (or carotid body tumors) are the most common of the head and neck tumors. Approximately 75% of all PGs do not produce catecholamines, and as a result present primarily as incidental findings or through mass effect, leading to a late diagnosis.
Most PGs are benign, with only 4%-15% developing metastases, 11, 12 usually isolated to regional lymph nodes. While surgery is commonly curative in benign PGs, the prognosis for malignant PGs remains poor, with 5-year mortality rates greater than 50%. 20 In this paper we present a rare case of a malignant, nonsecreting, carotid body PG with spinal metastasis, and discuss adjuvant treatments and management strategies.
case report

History and Examination
A 77-year-old woman presented to our institution with a 5-week history of progressive weakness of her lower extremities. She had experienced an increasing frequency of falls, to the point that the patient had become nonambulatory over the last 2 days. No bowl or bladder disturbances had been noted, but a loss of sensation to the bilateral lower extremities was also described. No other constitutional symptoms were described, including absence of weight loss, heat/cold intolerance, episodes of diaphoresis, or palpitations. Examination of the patient revealed bilateral lower-extremity motor weakness in all muscle groups, with loss of light touch and pinprick sensation. A sensory level was determined at the costal margin, with normal rectal tone. Upper extremity strength was normal. Systemic examination revealed a small pulsatile mass in the right neck medial to the sternocleidomastoid. The mass was firm with free mobility in the rostrocaudal direction without medial lateral mobility. There were no other palpable masses or lymphadenopathy, and normal thyroid palpation. No other systemic findings were noted.
An initial CT scan performed on the vertebral column revealed extensive spinal metastatic disease (Fig. 1A) , with the largest destructive lesion found at T-3, demonstrating extensive erosion of the vertebral body and pedicles. Epidural extension of the lesion was found at this level with associated spinal stenosis and cord compression. CT of the neck, along with chest, abdomen, and pelvic imaging revealed a 2 × 3 × 3-cm enhancing lesion centered on the right common carotid artery bifurcation (Fig. 2) . No other organ lesions were found, including normal thyroid imaging. At this time, imaging was suspicious of a carotid body tumor, although likely as an incidental finding, as well as extensive metastatic disease of an unknown primary site.
Operation
As a result of these findings further investigation was planned for the patient, including mammography, urine and serum metanephrines, serum calcitonin levels, and MRI. Serum laboratory values revealed no abnormalities, and the patient demonstrated absence of urinary metanephrines. MRI confirmed extensive osseous metastases, most advanced at T-3, where extradural extension was resulting in cord compression with associated signal intensity changes ( Fig. 1B and C) . The right carotid body lesion was again visualized, with splaying of the internal and external carotid arteries, confirming a suspected diagnosis of a carotid body PG (Fig. 2) . Due to the rarity of malignant degeneration of carotid body PGs presenting with vertebral metastases, the patient underwent radiologically guided needle biopsy of her right carotid body lesion, as well as an L-3 vertebral body lesion biopsy. Although the pathology from the vertebral biopsy was inconclusive, histological examination of the right carotid body lesion confirmed the suspicion of a PG. Due to progressive neurological decline and imaging confirmation of spinal compression, the patient underwent an operation for thoracic decompression with posterolateral fixation from T-1 to T-5. A wide laminectomy was performed between T-2 and T-4 with partial bilateral facetectomy at T-3. At this time, a highly vascular epidural mass was encountered from which a biopsy specimen was obtained. Resection of this epidural mass was attempted, but due to the high vascularity of the lesion, extensive resection was abandoned once the spinal canal was believed to be adequately decompressed. Histological examination of this specimen was consistent with a PG, with visualized tumor cells arranged in distinct nests separated by fibrovascular stroma and sustenacular cells (Fig.  3) . On immunohistochemical examination, the chief cells located within the nests were positive for chromogranin, while sustanacular cells stained positively for S100 protein.
Two independent pathologists, following outside consultation, confirmed the pathology.
Postoperative Course
Due to the rarity of this disease there are no current guidelines on management. Considering the patient's age and neurological status, she received local radiation therapy of 40 Gy in 20 fractions to the local disease at T-3, alongside sunitinib chemotherapy. She remains on sunitinib treatment 2 years after surgical therapy with stable disease, with no new lesions. MRI performed 2 years postoperatively demonstrated a significant reduction of epidural disease at T-3, with no evidence of cord compression. The suspected primary lesion at the carotid bifurcation also remains stable in size. Neurologically, the patient has made a complete recovery with independent ambulation.
discussion
Malignant carotid PGs are defined by the pathological confirmation of tumor cells at distant locations rather than histological grading of the primary tumor. 17 However, the incidence of metastasis is rare, representing only 4% to 15% of all head and neck tumors, 3, 11, 12 with only a 6% reported rate for carotid body tumors. 8 The majority of these metastases occur in regional lymph nodes (50%), with the remainder occurring in the liver and lungs. Vertebral metastases are exceedingly rare, with only isolated case reports describing them. 4, 5, 18, 21 Our paper reports the first case in the literature in which a patient primarily presented with widespread vertebral metastasis with spinal compression from a carotid body PG. In those patients with regionally metastatic disease, primary resection with adjuvant radiation therapy offers a prognostic advantage. However, due to the rarity of distant organ metastases, optimal treatment strategies remain to be identified. These cases are often treated with systemic chemotherapeutics, but this strategy arises from studies that have focused on thoracic and abdominal PGs. These tumors remain biologically distinct compared with head and neck PGs.
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PGs can be classified as sympathetic when arising from the sympathetic autonomic nervous system of the thorax, abdomen, or pelvis, or parasympathetic when arising in the paraganglia of the head and neck. Sympathetic tumors are of chromaffin origin and are often secretory, resulting in palpitations, headaches, diaphoresis, and weight loss due to the effects of systemic catecholamines. 3, 17 A significant number of sympathetic PGs (15%-23%) are metastatic. In contrast, head and neck parasympathetic PGs are hormonally silent and rarely malignant. As a result, they often present incidentally or through local mass effect. 16 Presentation with distant metastases is extremely rare and is often only reported as a recurrence several years following primary tumor resection.
Metastatic disease to the vertebrae is determined by radiological imaging (CT and MRI), although neither of these modalities aid in differentiating tumor types. Thus, diagnosis is only confirmed by histological and immunohistochemical analysis of tissue. There have been several reported instances in which metastatic medullary carcinoma of the thyroid was believed to represent a PG. 7 The pathological similarity of these lesions is well established, 8, 22 although PGs usually do not stain for calcitonin, further emphasizing the importance of thyroid scans and serum calcitonin levels in routine evaluation of suspected metastatic PGs. Radionucleotide studies can be used to determine metastatic disease in some patients. I 131 -MIBG (iodine-131 meta-iodobenzylguanidine) has shown increased uptake by chromaffin cells, even in nonsecreting tumors. This imaging modality was considered in our own patient due to the nondiagnostic nature of 2 needle biopsies. However, the need for spinal decompression for worsening neurological status led us to proceed directly to surgery. In patients where the diagnosis can been made preoperatively, angiographic embolization of major feeding blood vessels can be performed to reduce intraoperative blood loss during resection. Considering the extent of metastatic disease present in our patient, it was not believed that the morbidity of complete resection would offer any survival advantage, and hence angiography was not considered.
The rarity of metastatic carotid body tumors makes their management clinically challenging. External beam radiation therapy remains palliative in the treatment of spinal metastasis, with response more effective in younger patients. 13 Limited metastasis to isolated vertebrae may benefit from resection following embolization, and adds to the effectiveness of radiation therapy.
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-MIBG has recently been shown to be of therapeutic benefit. Where uptake is noted, this radio-iodinated treatment can produce palliation of bone pain, 10 and has been observed to show a partial tumor response with a 75% 5-year survival rate. 2, 6, 19 Chemotherapy remains the mainstay of treatment for systemic metastatic tumors. Various agents have been used, with combinations including cisplatin and vincristine. Although no consistent benefit has been demonstrated, up to 92% can achieve stable disease. 13, 15 Due to the small number of cases and the differences in groups receiving various treatment modalities, direct comparisons are difficult, and no proven treatment guidelines exist. Sunitinib, a potent inhibitor of multiple tyrosine kinase receptors, and an effective antiangiogenic drug, has been reported in some case series to benefit patients with sympathetic PG, 1 but its role in head and neck PGs remains to be elucidated.
conclusions
A case of vertebral metastasis from a malignant carotid body tumor is presented. This case highlights the need for clinical suspicion of this rare entity and the difficulties faced in its management. Resection with radiation therapy remains the mainstay of treatment where feasible, and systemic chemotherapy aids in systemic control.
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